Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617 in a Prostatectomy Model (LUTACT Trial)

NCT07054346 is registered in ClinicalTrials.gov with Thomas Hope as lead sponsor.

NCT NCT07054346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07054346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617 in a Prostatectomy Model (LUTACT Trial)
Lead sponsor
Thomas Hope
Phase
Phase 1
Overall status
Recruiting
Start date
July 8, 2025
Completion date
April 30, 2028
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk prostate cancer, localized prostate carcinoma, prostate cancer, prostate cancer (diagnosis), very high risk prostate carcinoma